CFO
GMED icon

Callan Family Office’s Globus Medical GMED Stock Holding History

Callan Family Office’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$205K Sell
2,596
-18
-0.7% -$1.53K ﹤0.01% 1144
2026
Q1 		$225K Buy
2,614
+111
+4% +$9.96K 0.01% 1031
2025
Q4 		$219K Buy
+2,503
New +$190K ﹤0.01% 1031

Other funds holding GMED

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Callan Family Office's GMED Position: Q2 2026 in Review

Callan Family Office reduced its Globus Medical (GMED) stake by 0.69% in Q2 2026, selling an estimated $1.53K and leaving 2,596 shares worth $205K. The position accounts for ﹤0.01% of the portfolio, ranked #1144.

Callan Family Office first reported a position in GMED in Q4 2025 and has held it in 3 quarters since. The position peaked at $225K in Q1 2026. 601 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

  • Callan Family Office held 2,596 shares of Globus Medical worth $205K as of Q2 2026.
  • Callan Family Office sold 18 Globus Medical shares in Q2 2026, an estimated $1.53K.
  • Globus Medical made up ﹤0.01% of Callan Family Office's portfolio in Q2 2026, its #1144 holding.
  • Callan Family Office first reported a position in Globus Medical in Q4 2025 and has held it in 3 quarters since.
  • Callan Family Office's Globus Medical position peaked at $225K in Q1 2026.
  • 601 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.